JP2023529640A5 - - Google Patents
Info
- Publication number
- JP2023529640A5 JP2023529640A5 JP2022574600A JP2022574600A JP2023529640A5 JP 2023529640 A5 JP2023529640 A5 JP 2023529640A5 JP 2022574600 A JP2022574600 A JP 2022574600A JP 2022574600 A JP2022574600 A JP 2022574600A JP 2023529640 A5 JP2023529640 A5 JP 2023529640A5
- Authority
- JP
- Japan
- Prior art keywords
- conjugate according
- group
- targeting agent
- cancer
- dendrimer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2020901833A AU2020901833A0 (en) | 2020-06-03 | Therapeutic conjugates | |
| AU2020901833 | 2020-06-03 | ||
| PCT/AU2021/050554 WO2021243415A1 (en) | 2020-06-03 | 2021-06-03 | Therapeutic conjugates |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023529640A JP2023529640A (ja) | 2023-07-11 |
| JP2023529640A5 true JP2023529640A5 (cg-RX-API-DMAC7.html) | 2024-06-10 |
Family
ID=78831413
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022574600A Pending JP2023529640A (ja) | 2020-06-03 | 2021-06-03 | 治療用コンジュゲート |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20240293588A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2023529640A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20230065935A (cg-RX-API-DMAC7.html) |
| CN (1) | CN115989039A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2021284918A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3180877A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021243415A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20180326081A1 (en) * | 2011-06-06 | 2018-11-15 | Starpharma Pty Ltd | Macromolecules |
| WO2023244828A1 (en) * | 2022-06-17 | 2023-12-21 | Purdue Research Foundation | Fibroblast activation protein-targeted nanoparticle magnetic resonance imaging agents |
| WO2024007034A2 (en) * | 2022-07-01 | 2024-01-04 | The Johns Hopkins University | Dendrimer-delivered alpha-particle radiotherapy for treatment of glioblastoma and other cancers in the brain |
| WO2024168199A1 (en) * | 2023-02-09 | 2024-08-15 | Regeneron Pharmaceuticals, Inc. | Antibody-drug conjugates via inverse electron demand diels-alder reactions |
| WO2026046228A1 (zh) * | 2024-08-27 | 2026-03-05 | 苏州拓界医药有限公司 | 树枝状聚合物偶联物及其制备方法 |
| CN120025408B (zh) * | 2025-04-23 | 2025-08-01 | 湖南中晟全肽生物科技股份有限公司 | 一种靶向fgfr2的多肽核素配体、探针及其应用 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5989294B2 (ja) * | 2006-01-20 | 2016-09-07 | スターファーマ・プロプライエタリー・リミテッドＳｔａｒｐｈａｒｍａ Ｐｔｙ Ｌｔｄ | 修飾高分子 |
| WO2009127691A1 (en) * | 2008-04-17 | 2009-10-22 | Ablynx N.V. | Peptides capable of binding to serum proteins and compounds, constructs and polypeptides comprising the same |
| CA2770980A1 (en) * | 2009-07-15 | 2011-01-20 | Roger Y. Tsien | Peptides whose uptake in cells is controllable |
| IN2014DN00101A (cg-RX-API-DMAC7.html) * | 2011-06-06 | 2015-05-15 | Starpharma Pty Ltd | |
| US20160106856A1 (en) * | 2012-08-14 | 2016-04-21 | Angiochem Inc. | Conjugates including an antibody moiety, a polypeptide that traverses the blood-brain barrier, and a cytotoxin |
| US9642916B2 (en) * | 2012-12-12 | 2017-05-09 | The Regents Of The University Of California | Porphyrin modified telodendrimers |
| US10550201B2 (en) * | 2013-03-13 | 2020-02-04 | Bioventures, Llc | Antibody-nanoparticle conjugates for the treatment of drug abuse |
| US10898594B2 (en) * | 2015-10-27 | 2021-01-26 | The Johns Hopkins University | PAMAM dendrimer based CEST imaging agents and uses thereof |
| JP7541978B2 (ja) * | 2018-11-29 | 2024-08-29 | スターファーマ ピーティーワイ エルティーディー | 治療および画像化のためのデンドリマー |
-
2021
- 2021-06-03 KR KR1020227046150A patent/KR20230065935A/ko active Pending
- 2021-06-03 AU AU2021284918A patent/AU2021284918A1/en active Pending
- 2021-06-03 WO PCT/AU2021/050554 patent/WO2021243415A1/en not_active Ceased
- 2021-06-03 US US17/928,306 patent/US20240293588A1/en active Pending
- 2021-06-03 JP JP2022574600A patent/JP2023529640A/ja active Pending
- 2021-06-03 CA CA3180877A patent/CA3180877A1/en active Pending
- 2021-06-03 CN CN202180049571.2A patent/CN115989039A/zh active Pending